CPT® Code 86663

The CPT® Code 86663 refers to a laboratory test that measures antibodies against the early antigen (EA) of the Epstein-Barr virus (EBV). This virus is known to cause infectious mononucleosis, a common viral infection primarily affecting children and young adults. The symptoms of this disease typically include fever, fatigue, sore throat, swollen lymph nodes, and in some cases, an enlarged spleen. EBV is transmitted through saliva, particularly during active infection, and it can persist in the body’s lymphocytes for life, occasionally reactivating without causing any symptoms. In addition to infectious mononucleosis, EBV is associated with certain serious conditions, including X-linked lymphoproliferative syndrome in males and various types of cancers such as Burkitt lymphoma, Hodgkin's lymphoma, and nasopharyngeal carcinoma. The early antigen (EA) IgG antibody test, represented by CPT® Code 86663, is specifically utilized to assist in diagnosing either an acute EBV infection or a reactivation of the virus. However, it is important to note that this test should not be used in isolation to diagnose the disease. Other related tests, such as the EBV nuclear antigen (EBNA) IgG antibody test (CPT® Code 86664) and the EBV viral capsid antigen (VCA) test for IgG and IgM antibodies (CPT® Code 86665), are also available and can provide additional information regarding past exposure to EBV and the diagnosis of primary EBV infectious mononucleosis when used in conjunction with other diagnostic tests. It is crucial to understand that the EBV VCA test for IgA antibodies is not suitable for diagnosing infectious mononucleosis but may be useful in detecting and assessing the prognosis of nasopharyngeal carcinoma. The test for CPT® Code 86663 requires a blood sample, which is obtained through a separately reportable venipuncture, and the serum is analyzed using a semi-quantitative chemiluminescent immunoassay method.